Search Within

Andriy Derkach

Formats
  1. Meeting Abstract (104)
  2. Journal Article (56)
  3. Research Letter (11)
  4. Correspondence (3)
Groups
  1. Biostatistics Service (174)
  2. Epidemiology and Biostatistics (174)
  3. Population Sciences Research Program (174)
  4. Department of Medicine (160)
  5. Hematologic Malignancies, Division of (159)
  6. Center for Hematologic Malignancies (153)

More Groups

People
  1. Urvi Shah (80)
  2. Malin Hultcrantz (79)
  3. Alexander Lesokhin (78)
  4. Carlyn Rose Tan (71)
  5. Sham Mailankody (71)
  6. Hani Hassoun (70)

More People

Years
  1. 2025 (10)
  2. 2024 (47)
  3. 2023 (44)
  4. 2022 (35)
  5. 2021 (22)
  6. 2020 (16)
Publications
  1. Blood (75)
  2. Clinical Lymphoma, Myeloma and Leukemia (21)
  3. Journal of Clinical Oncology (14)
  4. Blood Advances (10)
  5. Leukemia and Lymphoma (6)
  6. Blood Cancer Journal (5)

More Publications

Publishers
  1. American Society of Hematology (85)
  2. Elsevier Inc. (24)
  3. American Society of Clinical Oncology (14)
  4. Nature Publishing Group (12)
  5. American Association for Cancer Research (8)
  6. Taylor & Francis Group (6)

More Publishers

Results (174)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia
    Journal Article

    Chin, K. K.; Valtis, Y.; Derkach, A.; Yisraeli Salman, M.; Boussi, L.; Ciervo, J.; Geyer, M. B.; Park, J. H.; Tallman, M. S.; Glass, J. L.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Belantamab mafodotin, nirogacestat and pomalidomide for patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; Hashmi, H.; Maclachlan, K. H.; Rajeeve, S.; Shah, U. A.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    Meeting Abstract

    Bewersdorf, J. P.; Derkach, A.; Zeidan, A. M.; Stein, E. M.; Mauro, M. J.; Podoltsev, N. A.; Rampal, R.
    Blood (2024)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Meeting Abstract

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G.; Borge, P.; Geyer, M. B.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-term follow-up of real-world teclistamab therapy for relapsed/refractory multiple myeloma from the IMWG Immunotherapy Working Group Committee
    Meeting Abstract

    Tan, C. R.; Asoori, S.; Nemirovsky, D.; Derkach, A.; Brunaldi, L.; Popat, R.; Lau, C.; Kastritis, E.; Martínez-Lopez, J.; Bansal, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Racial differences in proportion of myeloma cases attributable to modifiable risk factors in the United States, 2016-21
    Meeting Abstract

    Anuraj, A.; Rath, D.; Derkach, A.; Usmani, S. Z.; Shah, U. A.
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Bleeding in lung cancer patients receiving therapeutic anticoagulation while being treated with VEGF and EGFR inhibitors
    Meeting Abstract

    Fusillo, T. F.; Leader, A.; Mantha, S.; Ajufo, H.; Derkach, A.; Schoenfeld, A.; Singh, R.; Kaplinsky, P.; Zwicker, J. I.
    Blood (2024)

    Fulltext@MSK | Save
  • Peri-procedural anticoagulation interruption in acute cancer associated thrombosis
    Meeting Abstract

    Gupta, A.; Feng, K.; Derkach, A.; Leader, A.; Patell, R.
    Blood (2024)

    Fulltext@MSK | Save
  • Initial results from the ASH research collaborative's COVID-19 outcomes in myeloma and the impact of vaccines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Usmani, S. Z.; Semmel, E. A.; James, S.; Wood, W. A.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; Zonder, J. A.; Rubinstein, S. M.; D'Souza, A.; more...
    Blood (2024)

    Fulltext@MSK | Save